Rosiglitazone: all 149 studies that test it
Page 1 of 2. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.
- Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor MalignanciesRecruitingNCT04114136Phase 2
- A Study of Pharmacokinetic Drug Interaction Study of the Hedgehog Pathway Inhibitor GDC-0449 in Combination With Rosiglitazone or Combined Oral Contraceptive in Patients With Locally Advanced or Metastatic Solid Tumors That Are Refractory to Standard Therapy or for Whom No Standard Therapy ExistsCompletedNCT01209143Phase 1Results posted
- Effect of Rosiglitazone on the Vascular Biology of Human Fat TissueCompletedNCT01150981Phase 2Results posted
- Thiazolidinedione Intervention With Vitamin D EvaluationTerminatedNCT00879970Phase 4Results posted
- A Study for Pre-diabetic Patients With Cholesterol Lowering DrugsCompletedNCT00831129Phase 2/3Results posted
- Rosiglitazone And Fenofibrate Additive Effects on Lipids (RAFAEL)TerminatedNCT00819910Phase 4Results posted
- Drug-Drug Interaction Study Between Quinine Sulfate and RosiglitazoneCompletedNCT00785213Phase 1Results posted
- Free Fatty Acid-Induced Hypertension in Obese Subjects With Type 2 DiabetesCompletedNCT00738023Phase 4Results posted
- Study In Postmenopausal Women With Type 2 Diabetes Looking At Approved Diabetes Drugs And How They Affect Bone HealthCompletedNCT00679939Phase 4Results posted
- Insulin Resistance, Polycystic Ovary Syndrome, and Bone Research StudyCompletedNCT00640224Phase 4Results posted
- EMPOWIR:Enhance the Metabolic Profile of Women With Insulin ResistanceCompletedNCT00618072Phase 2Results posted
- Rosiglitazone in Treating Patients With Pituitary TumorsTerminatedNCT00616642Phase 2Results posted
- The Use of Rosiglitazone to Treat AsthmaCompletedNCT00614874Phase 2Results posted
- Rosiglitazone in Treating Patients With Newly Diagnosed ACTH-Secreting Pituitary Tumor (Cushing Disease)TerminatedNCT00612066Phase 2Results posted
- The Effect of Glitazone Treatment on Bone Marrow and Bone Marrow CellsCompletedNCT00609362Phase 2Results posted
- Effects of Fatty Acid Delivery on Heart Metabolism and Function in Type 2 Diabetes (T2DMCompletedNCT00577590Not applicableResults posted
- Gene Regulation by ThiazolidinedionesCompletedNCT00567593Phase 4Results posted
- Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate AlzheimersTerminatedNCT00550420Phase 3Results posted
- Open-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate AlzheimersTerminatedNCT00490568Phase 3Results posted
- A Study Of BRL49653C For The Treatment Of Type 2 Diabetes (Combination Therapy With Sulfonyl Urea) -With Placebo StudyCompletedNCT00432679Phase 3Results posted
- Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's DiseaseCompletedNCT00428090Phase 3Results posted
- Effect of Rosiglitazone Versus Placebo on Cardiovascular Performance and Myocardial TriglycerideCompletedNCT00424762Phase 4Results posted
- Effects of Rosiglitazone on the Metabolic Phenotype of Impaired Glucose Tolerance in YouthCompletedNCT00413335Not applicableResults posted
- Open-Label Extension Assessing Long-Term Safety Of Rosiglitazone In Subjects With Mild To Moderate Alzheimer's DiseaseCompletedNCT00381238Phase 2Results posted
- RECORD: Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in DiabetesCompletedNCT00379769Phase 3Results posted
- Rosiglitazone Effect on Mitochondria and LipoatrophyCompletedNCT00367744Phase 2Results posted
- Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's DiseaseCompletedNCT00348309Not applicableResults posted
- Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's DiseaseCompletedNCT00348140Phase 3Results posted
- Rosiglitazone for Clozapine Induced Glucose Metabolism ImpairmentCompletedNCT00337350Phase 4Results posted
- Effects of Rosiglitazone on Renal Hemodynamics and Proteinuria of Type 2 Diabetic Patients With Renal Insufficiency Due to Overt Diabetic NephropathyCompletedNCT00324675Not applicableResults posted
- Brain Imaging Study Of Rosiglitazone Efficacy And Safety In Alzheimer's DiseaseCompletedNCT00265148Phase 2Results posted
- Insulin Resistance in Non-alcoholic Fatty Liver DiseaseTerminatedNCT00252499Not applicableResults posted
- Insulin Resistance in Patients With Mood DisorderCompletedNCT00242619Not applicableResults posted
- Preferred Treatment of Type 1.5 DiabetesCompletedNCT00194896Not applicableResults posted
- Comparing Tricor, Avandia, or Weight Loss to Lower Cardiovascular Risk Factors in People With High Triglycerides.CompletedNCT00186537Not applicableResults posted
- Combination Drug Study of Bexarotene and Rosiglitazone to Treat CTCLCompletedNCT00178841Phase 2Results posted
- An Evaluation of Exenatide and Rosiglitazone in Subjects With Type 2 Diabetes MellitusCompletedNCT00135330Phase 3Results posted
- Avandia™ + Amaryl™ or Avandamet™ Compared With Metformin (AVALANCHE™ Study)CompletedNCT00131664Phase 3Results posted
- Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin ResistanceCompletedNCT00130286Phase 1/2Results posted
- Vascular Effects of Rosiglitazone Versus Glyburide in Type 2 Diabetic PatientsCompletedNCT00123643Phase 4Results posted
- Rosiglitazone Versus a Sulfonylurea On Progression Of Atherosclerosis In Patients With Heart Disease And Type 2 DiabetesCompletedNCT00116831Phase 3Results posted
- Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY)CompletedNCT00081328Phase 3Results posted
- A Trial of Rosiglitazone for Ulcerative ColitisCompletedNCT00065065Phase 2Results posted
- Glycemic Control and Complications in Diabetes Mellitus Type 2 (VADT)CompletedNCT00032487Phase 3Results posted
- Effect of Metformin and Rosiglitazone Over no Diabetic With Metabolic Syndrome Patients.CompletedNCT04148183Phase 2/3
- A Pilot Study of Rosiglitazone in the Treatment of GH Secreting Pituitary AdenomasStatus unknownNCT03309319Not applicable
- Rosiglitazone Adjunctive Therapy for Severe Malaria in ChildrenCompletedNCT02694874Not applicable
- Effects of Rosiglitazone and Metformin on Metabolism in Type 2 DiabetesCompletedNCT02526615Phase 4
- Identification of Null Allelic Variant of CYP2C8 In A Korean PopulationCompletedNCT01872780Phase 1
- A Study to Evaluate the Efficacy and Safety of BRL 49653C in Non-insulin Dependent DiabetesCompletedNCT01706211Phase 3
- Compare the Pharmacokinetics of Omeprazole, Rosiglitazone, and Desipramine When Administered With Avanafil in Healthy Male SubjectsCompletedNCT01415128Phase 1
- Effects of Rosiglitazone and Alpha-lipoic Acid on the Patients With Pathologically Proved NASHTerminatedNCT01406704Phase 4
- A Study to Assess the Effect Tasimelteon on the Cytochrome P450 3A4 and 2C8 Enzymes in Healthy SubjectsCompletedNCT01402076Phase 1
- BAY73-4506 Probe Substrate StudyCompletedNCT01287598Phase 1
- A Drug-Drug Interaction Study of the Effects of XL184 (Cabozantinib) on Rosiglitazone in Subjects With Solid TumorsCompletedNCT01100619Phase 1
- Role of Insulin Action and Free Fatty Acids in Hyperandrogenism of Women With Polycystic Ovary SyndromeCompletedNCT01019356Not applicable
- Validation Study of Multiple Probe Compounds for Drug Interaction EvaluationCompletedNCT00964106Phase 1
- Influence of Glitazones on the Vasodilatory Effect of High-density Lipoprotein (HDL) LipoproteinsCompletedNCT00953498Phase 4
- A First Time in Human Study in Healthy Volunteers to Investigate a New Medicine to Treat MalariaTerminatedNCT00811356Phase 1
- Insulin Resistance and Intramyocellular Lipid Content in Glucose Intolerant Subjects Receiving RosiglitazoneCompletedNCT00746174Phase 4
- PK, Dose Proportionality, Food Effect And Repeat Dose Study Of Rosiglitazone XR In Healthy VolunteersCompletedNCT00733785Phase 1
- Rosiglitazone Therapy In The Prevention Of Coronary Artery Disease In Patients With Impaired Glucose ToleranceStatus unknownNCT00733174Phase 4
- Mild Alzheimer''s Disease to Assess the of Extended Release Formulation of Rosiglitazone (RSG XR)CompletedNCT00688207Phase 1
- Physical Exercise Versus Rosiglitazone in CAD and PrediabetesCompletedNCT00675740Phase 4
- Diagnosis and Therapy of Vulnerable Atherosclerotic PlaqueCompletedNCT00636766Not applicable
- Effect of GSK376501 on CYP450 Activity in Healthy Adult SubjectsCompletedNCT00615212Phase 1
- Effect of Thiazolidinedione Treatment Vascular Risk MarkersCompletedNCT00571506Phase 4
- Study to Determine the Utility of Novel Technologies and Biomarkers to Measure Human Response to Rosiglitazone MaleateCompletedNCT00551564Phase 1
- Effect of Rosiglitazone on Myocardial Blood Flow Regulation in Type 2 DiabetesCompletedNCT00549874Not applicable
- A Study Of BRL49653C For The Treatment Of Type 2 DiabetesCompletedNCT00523913Phase 3
- Effects of Rosiglitazone on Serum Ghrelin and Peptide YY LevelsCompletedNCT00522470Phase 4
- Targeting Peroxisome Proliferator-activated Receptor-gamma in Peritoneal Dialysis Patients - Will it Reduce Inflammation, Atherosclerosis, Calcification and Improve Survival of Peritoneal Dialysis Patients?Status unknownNCT00516880Not applicable
- The Pharmacokinetic Interaction Between Oral Casopitant and Oral Dolasetron, Granisetron or Rosiglitazone in SubjectsCompletedNCT00511823Phase 1
- Comparison of the Efficacy and Tolerability of the Addition of AVANDIA to Submaximal Doses of MetforminCompletedNCT00501020Phase 4
- Rosiglitazone on Microalbuminuria in Type 2 DiabeticsCompletedNCT00500955Phase 3
- Efficacy and Safety Study of Rosiglitazone/Metformin Therapy vs Rosiglitazone and Metformin in Type 2 Diabetes SubjectsCompletedNCT00499707Phase 3
- A One-Year, Randomized, Double-Blind, Placebo-Controlled Trial of Rosiglitazone in Non-Alcoholic SteatohepatitisCompletedNCT00492700Phase 2
- To Investigate the Effect of Rosiglitazone and Ramipril on Pre-clinical Vasculopathy in Diabetes and IGT PatientsCompletedNCT00489229Phase 3
- Effects of ROSIglitazone on Inflammatory Markers and Adipokines in Diabetic Patients Using an Angiotensin Receptor Blocker (TELmisartan) - The ROSITEL StudyCompletedNCT00486187Not applicable
- Treatment of Hyperglycaemia and Insulin Resistance in HIV Infected PatientsCompletedNCT00483392Not applicable
- Ppar-Gamma EliminAtes Restenosis Longevity Study: PEARLSTerminatedNCT00465296Phase 3
- Rosiglitazone and Insulin Resistance in Renally Impaired PatientsTerminatedNCT00452166Phase 3
- A Placebo-controlled Study to Investigate the Safety, and Pharmacokinetics of Oral GSK626616AC in Healthy SubjectsCompletedNCT00443170Phase 1
- Effects of Rosiglitazone on Bone in Postmenopausal Diabetic WomenCompletedNCT00440375Phase 4
- Effect of Inhaled Pre-prandial Human Insulin on Blood Glucose Control in Type 2 DiabetesTerminatedNCT00427154Phase 3
- Fluid Retention in Rosiglitazone Treated Subjects With Autonomic Neuropathy.CompletedNCT00422955Phase 3
- Effect of Rosiglitazone on ADMA in Critical IllnessStatus unknownNCT00409097Phase 3
- The Effect of Rosiglitazone on Ischemia-reperfusion-injury Using Annexin A5 Scintigraphy.CompletedNCT00405015Phase 2
- The Anti-Inflammatory And Metabolic Effects Of Rosiglitazone In Subjects With Rheumatoid ArthritisCompletedNCT00379600Phase 2
- Metabolic Effects of Treatment in Patients With Recently Diagnosed Type 2 DiabetesCompletedNCT00373178Phase 4
- Rosiglitazone and Insulin in T1DM AdolescentsCompletedNCT00372086Phase 4
- 11ß-HSD1 and Metabolic SyndromeCompletedNCT00370305Phase 2
- Rosiglitazone Maleate in Treating Patients With Oral LeukoplakiaCompletedNCT00369174Phase 2
- Effect of Rosiglitazone in Nondiabetic Patients With the Metabolic SyndromeCompletedNCT00364221Phase 4
- Drug Interaction Study With Atazanavir Administered With and Without Ritonavir and a Cytochrome P450 Substrate RosiglitazoneCompletedNCT00362726Phase 1
- Insulin Glargine v Rosiglitazone as add-on Therapy in Patients Failing Sulfonylurea and Metformin Combination TherapyCompletedNCT00358124Phase 4
- A Study Of Rosiglitazone Plus Insulin To Treat Type 2 Diabetes Mellitus PatientsCompletedNCT00349427Phase 3
- Efficacy and Safety of Inhaled Pre-prandial Human Insulin in Type 2 DiabetesTerminatedNCT00348712Phase 3
- Effects Of Rosiglitazone (Extended Release Tablets) On Cerebral Glucose Utilisation And Cognition Alzheimers DiseaseTerminatedNCT00334568Phase 2
- AVANDIA With Glyburide In African American And Hispanic Patients With Type 2 Diabetes Not Controlled by Glyburide AloneCompletedNCT00333723Phase 4